Nox2 activation in Covid-19

[1]  G. d’Ettorre,et al.  Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. , 2020, Circulation research.

[2]  Quynh Nguyen,et al.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System , 2020, Circulation research.

[3]  G. Oudit,et al.  Angiotensin Converting Enzyme 2: A Double-Edged Sword. , 2020, Circulation.

[4]  T. Münzel,et al.  Nox2+ Myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1. , 2020, Cardiovascular research.

[5]  Lei Liu,et al.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.

[6]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[7]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[8]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[9]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[10]  G. Buettner,et al.  Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice. , 2019, Blood advances.

[11]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[12]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[13]  F. Violi,et al.  Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. , 2017, Antioxidants & redox signaling.

[14]  S. Lewin,et al.  Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy , 2017, Nature Communications.

[15]  F. Violi,et al.  NADPH Oxidase-2 and AtherothrombosisHighlights , 2017 .

[16]  Xiaoping Du,et al.  Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Marc P. Bonaca,et al.  Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis–Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50) , 2016, Circulation.

[18]  A. Farcomeni,et al.  Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia , 2015, Thorax.

[19]  Alessio Farcomeni,et al.  Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation , 2014, Thrombosis and Haemostasis.

[20]  VioliFrancesco,et al.  Clinical Application of NOX Activity and Other Oxidative Biomarkers in Cardiovascular Disease: A Critical Review , 2014 .

[21]  S. Basili,et al.  NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. , 2013, International journal of cardiology.

[22]  Min Zhang,et al.  NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies , 2011, Basic Research in Cardiology.

[23]  A. Plebani,et al.  Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.